Date: 2/3/2005
Dr. Anders Waldenstrom presents a brief family history and a moving tribute to his father, Dr. Jan Waldenstrom, whose life and times were rich with the traditions of medical research.
Running Time: 5:49
Size: 3.38 MB
Latest Bing Center News
Progress in the Treatment of Waldenstrom’s Macroglobulinemia (WM)
Workshop Date and Time: Wednesday, April 21, 2021, 12:30 – 1:30pm (EDT). Registrants can listen in live over the phone or online as a webcast. This will be the 8th collaboration between IWMF and CancerCare in a Connect® Education Workshop on WM. CancerCare, is the leading national organization in the U.S. providing free, professional support services and information to help people manage the emotional, practical and financial challenges of cancer.
LLS Patient Education: Waldenstrom’s Macroglobulinemia Update
Please join LLS and Memorial Cancer Institute for a free virtual education program for patients and their families. Presenters will discuss the latest advances in Waldenstrom’s Macroglobulinemia from diagnosis to living with the disease.
A Guide to CXCR4 Mutations and their Importance in Waldenstrom's Macroglobulinemia
The April 2021 IWMF Torch (issue 22.2) is Now Online!
Ask the Doctors LIVE: WM and the COVID Vaccine
March 31, 2021 Webinar: Our IWMF experts will share an update on the status of existing vaccines and others in development. This interactive LIVE question and answer session will explain side effects and recommendations for WM patients.
Treatment Advancements are Improving Survivorship and Prompting Hope
Is a cure for Waldenstrom macroglobulinemia on the horizon? In the past several decades Waldenstrom’s survivorship has vastly improved due to safer and more effective treatment drugs. Could this indicate that a cure might be within reach?
New Treatment Options for Waldenstrom Macroglobulinemia
New combination drug regimens are being studied for the treatment of Waldenstrom macroglobulinemia (WM). In this segment, Dr. Jorge Castillo, MD, of Dana-Farber Cancer Institute updates patients on the information presented at the recent American Society of Hematology (ASH) conference and suggests that Waldenstrom patients pay attention to the combination of ibrutinib and rituximab (INNOVATE Study), that have shown faster and deeper responses over time versus rituximab alone.
A 70-year-old New Brunwick man to walk 300 kilometres for rare cancer awareness
A Rothesay man fighting a rare cancer is stepping up to raise awareness about the disease. And as Travis Fortnum reports, he’s planning a month-long walk to do it.
2021 IWMF Global Educational Webinar with Dr. Stephen Ansell & Dr. Jorge Castillo
Our IWMF experts will share an update on the status of existing COVID-19 vaccines and others in development. This interactive LIVE question and answer session will explain side effects and recommendations for WM patients.
Clinical Trials Are Moving Out of the Lab and Into Peopleʼs Homes
After the pandemic forced thousands of trials to shut down, researchers found clever ways to conduct human studies remotely — while reaching more people, quickly and cheaply.
Current and Future Treatments for Waldenstrom Macroglobulinemia
What are the treatments for Waldenstrom macroglobulinemia and what's in the pipeline? Can Waldenstrom patients plan for a higher quality of life? Dr. Jorge Castillo, Clinical Director, Bing Center for Waldenstrom Macroglobulinemia, Dana Farber Cancer Institute, presents an overview of his presentation at the 2020 IWMF with Patient Power co-founder Andrew Schorr.